The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
The definition of tuberculosis infection based on the spectrum of tuberculosis disease
Open accessAbstract
Latent tuberculosis infection was the term traditionally used to indicate tuberculosis (TB) infection. This term was used to define “a state of persistent immune response to stimulation by Mycobacterium tuberculosis antigens through tests such as the tuberculin skin test (TST) or an interferon-γ release assay (IGRA) without clinically active TB”. Recent evidence indicates that the spectrum from TB infection to TB disease is much more complex, including a “continuum” of situations didactically reported as uninfected individual, TB infection, incipient TB, subclinical TB without signs/symptoms, subclinical TB with unrecognised signs/symptoms, and TB disease with signs/symptoms. Recent evidence suggests that subclinical TB is responsible for important M. tuberculosis transmission. This review describes the different stages described above and their relationships. It also summarises the new developments in prevention, diagnosis and treatment of TB infection as well as their public health and policy implications. Educational aims: To describe the evolution of the definition of “tuberculosis infection” and didactically describe the continuum of stages existing between TB infection and disease. To discuss the recommended approaches to prevent, diagnose and treat TB infection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The global prevalence of latent tuberculosis: A systematic review and meta-analysis
Cohen, A., Mathiasen, V. D., Schön, T., & Wejse, C. (2019) · European Respiratory Journal · doi:10.1183/13993003.00655-2019 · Cited by 547
Frascella, B., Richards, A. S., Sossen, B., Emery, J. C., Odone, A., Law, I., Onozaki, I., Esmail, H., & Houben, R. M. G. J. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1402 · Cited by 315
Research works printed but not linked: 60
- Loddenkemper R , Murray JF . History of tuberculosis. In: Migliori GB , Raviglione MC , eds. Essential Tuberculosis. Cham, Springer Nature Switzerland AG, 2021; pp. 6–9.
- Tagliani E , Nikolayevskyy V , Tortoli E , et al. Laboratory diagnosis of tuberculosis. In: Migliori GB , Bothamley G , Duarte R , Rendon A , eds. Tuberculosis (ERS Monograph). Sheffield, European Respiratory Society, 2018; pp. 99–115. · DOI
- 10.1183/13993003.00391-2019 · DOI
- Goletti D , Martineau AR . Pathogenesis and immunology of tuberculosis. In: Migliori GB , Raviglione MC , eds. Essential Tuberculosis. Cham, Springer Nature Switzerland AG, 2021; pp. 20–28. · DOI
- Barreira-Silva P , Torrado E , Nebenzahl-Guimaraes H , et al. Aetiopathogenesis, immunology and microbiology of tuberculosis. In: Migliori GB , Bothamley G , Duarte R , Rendon A , eds. Tuberculosis (ERS Monograph). Sheffield, European Respiratory Society, 2018; pp. 62–82. · DOI
- Goletti, 2018, Preventive therapy for tuberculosis in rheumatological patients undergoing therapy with biological drugs, Expert Rev Anti Infect Ther, 16, 501, 10.1080/14787210.2018.1483238 · DOI
- Petrone, 2015, Blood or urine IP-10 cannot discriminate between active tuberculosis and respiratory diseases different from tuberculosis in children, Biomed Res Int, 2015, 589471, 10.1155/2015/589471 · DOI
- 10.1183/13993003.01727-2020 · DOI
- Boulle A , Davies MA , Hussey H , et al. Risk factors for coronavirus disease 2019 (COVID-19) death in a population cohort study from the Western Cape Province, South Africa. Clin Infect Dis 2020; in press [https://doi.org/10.1093/cid/ciaa1198]. · DOI
- Faqihi, 2020, COVID-19 in a patient with active tuberculosis: a rare case-report, Respir Med Case Rep, 31, 101146
- Motta, 2020, Tuberculosis, COVID-19 and migrants: preliminary analysis of deaths occurring in 69 patients from two cohorts, Pulmonology, 26, 233, 10.1016/j.pulmoe.2020.05.002 · DOI
- Musso M , Di Gennaro F , Gualano G , et al. Concurrent cavitary pulmonary tuberculosis and COVID-19 pneumonia with in vitro immune cell anergy. Infection 2021; in press [https://doi.org/10.1007/s15010-021-01576-y]. · DOI
- Davies MA . HIV and risk of COVID-19 death: a population cohort study from the Western Cape Province, South Africa. medRxiv 2020; preprint [https://doi.org/10.1101/2020.07.02.20145185]. · DOI
- Riou, 2021, Relationship of SARS-CoV-2-specific CD4 response to COVID-19 severity and impact of HIV-1 and tuberculosis co-infection, J Clin Invest, 131, e149125, 10.1172/JCI149125 · DOI
- 10.1183/13993003.01245-2015 · DOI
- Migliori, 2021, Tuberculosis, COVID-19 and hospital admission: consensus on pros and cons based on a review of the evidence, Pulmonology, 27, 248, 10.1016/j.pulmoe.2020.12.016 · DOI
- 10.1183/13993003.01398-2020 · DOI
- 10.1038/nrmicro2236 · DOI
- Lewinsohn, 2019, New concepts in tuberculosis host defense, Clin Chest Med, 40, 703, 10.1016/j.ccm.2019.07.002 · DOI
- 10.3899/jrheum.140097 · DOI
- 10.1128/CMR.00021-18 · DOI
- 10.1098/rstb.2013.0437 · DOI
- 10.1183/13993003.01957-2019 · DOI
- Mendelsohn, 2021, Validation of a host blood transcriptomic biomarker for pulmonary tuberculosis in people living with HIV: a prospective diagnostic and prognostic accuracy study, Lancet Glob Health, 9, e841, 10.1016/S2214-109X(21)00045-0 · DOI
- 10.1016/S1473-3099(20)30914-2 · DOI
- Kendall, 2021, Reply to: subclinical tuberculosis: some flies in the ointment, Am J Respir Crit Care Med, 203, 1328, 10.1164/rccm.202102-0367LE · DOI
- 10.1111/tmi.12534 · DOI
- 10.1371/journal.pone.0038691 · DOI
- Patterson, 2019, Is cough really necessary for TB transmission?, Tuberculosis (Edinb), 117, 31, 10.1016/j.tube.2019.05.003 · DOI
- Esmail, 2018, Tuberculosis transmission during the subclinical period: could unrelated cough play a part?, Lancet Respir Med, 6, 244, 10.1016/S2213-2600(18)30105-X · DOI
- Styblo, 1985, The relationship between the risk of tuberculous infection and the risk of developing infectious tuberculosis, Bull Int Union Tuberc Lung Dis, 60, 117
- Goletti, 2018, Update on tuberculosis biomarkers: from correlates of risk, to correlates of active disease and of cure from disease, Respirology, 23, 455, 10.1111/resp.13272 · DOI
- 10.1183/13993003.00510-2016 · DOI
- 10.1016/S0140-6736(03)12950-9 · DOI
- Hamada Y , den Boon S , Cirillo DM , et al. Framework for the evaluation of new tests for tuberculosis infection. Eur Respir J 2021; 58: 2004078. doi:10.1183/13993003.04078-2020 · DOI
- 10.1016/j.micinf.2004.09.004 · DOI
- Petrone, 2016, Blood and urine inducible protein 10 as potential markers of disease activity, Int J Tuberc Lung Dis, 20, 1554, 10.5588/ijtld.16.0342 · DOI
- Petrone, 2018, Evaluation of IP-10 in Quantiferon-Plus as biomarker for the diagnosis of latent tuberculosis infection, Tuberculosis (Edinb), 111, 147, 10.1016/j.tube.2018.06.005 · DOI
- 10.1016/S1473-3099(18)30355-4 · DOI
- 10.1016/S0140-6736(15)01316-1 · DOI
- 10.1038/nm.4161 · DOI
- 10.3899/jrheum.140099 · DOI
- Nikitina, 2019, Comparative performance of QuantiFERON-TB Gold versus skin test with tuberculosis recombinant allergen (Diaskintest) among patients with suspected pulmonary tuberculosis in Russia, Int J Infect Dis, 86, 18, 10.1016/j.ijid.2019.06.014 · DOI
- Ruhwald, 2017, Safety and efficacy of the C-Tb skin test to diagnose Mycobacterium tuberculosis infection, compared with an interferon γ release assay and the tuberculin skin test: a phase 3, double-blind, randomised, controlled trial, Lancet Respir Med, 5, 259, 10.1016/S2213-2600(16)30436-2 · DOI
- Belay, 2021, Detection of Mycobacterium tuberculosis complex DNA in CD34-positive peripheral blood mononuclear cells of asymptomatic tuberculosis contacts: an observational study, Lancet Microbe, 2, e267, 10.1016/S2666-5247(21)00043-4 · DOI
- Bender, 1991, Identification and comparison of CD34-positive cells and their subpopulations from normal peripheral blood and bone marrow using multicolor flow cytometry, Blood, 77, 2591, 10.1182/blood.V77.12.2591.2591 · DOI
- Reece, 2018, Mycobacterium tuberculosis-infected hematopoietic stem and progenitor cells unable to express inducible nitric oxide synthase propagate tuberculosis in mice, J Infect Dis, 217, 1667, 10.1093/infdis/jiy041 · DOI
- 10.1371/journal.pone.0169119 · DOI
- Verma, 2020, A novel, high-sensitivity, bacteriophage-based assay identifies low-level Mycobacterium tuberculosis bacteremia in immunocompetent patients with active and incipient tuberculosis, Clin Infect Dis, 70, 933
- 10.1183/16000617.0035-2018 · DOI
- WHO Regional Office for Europe . Tuberculosis elimination in the WHO European Region: review of key actions, with a special focus on tuberculosis infection management. Copenhagen, WHO Regional Office for Europe, 2020.
- Lange, 2020, Perspective for precision medicine for tuberculosis, Front Immunol, 11, 566608, 10.3389/fimmu.2020.566608 · DOI
- 10.1183/16000617.0377-2020 · DOI
- 10.1016/j.smim.2014.09.008 · DOI
- 10.1016/j.cell.2011.12.023 · DOI
- 10.1016/j.cell.2012.01.026 · DOI
- DiNardo, 2020, DNA hypermethylation during tuberculosis dampens host immune responsiveness, J Clin Invest, 130, 3113, 10.1172/JCI134622 · DOI
- 10.1183/09031936.00214014 · DOI
- 10.1016/S1473-3099(16)30216-X · DOI
- Migliori, 2019, Global tuberculosis network (GTN). Evolution of programmatic definitions used in tuberculosis prevention and care, Clin Infect Dis, 68, 1787, 10.1093/cid/ciy990 · DOI
Cited by
Sorted by citations
Items 101–149 of 149
Kurniawan, K., Djakaria, I., Indrayani, A., & Ajami, F. M. (2026) · Sanitasi: Jurnal Kesehatan Lingkungan · doi:10.29238/sanitasi.v19i1.3060 · Cited by 1
Manoharan, A., Sharma, M., & Theivendren, P. (2026) · In Silico Research in Biomedicine · doi:10.1016/j.insi.2026.100276 · Cited by 1
Chumpa, N., Ohata, P. J., & Suwanpimolkul, G. (2025) · BMC Public Health · doi:10.1186/s12889-025-25491-1 · Cited by 1
“Without preventive treatment, the risk of acquiring TB is 10% annually among people living with HIV (PLWH) and 50% over their lifetime [3, 4].”
RapTB: a lung-derived hemoglobin fragment with activity against Mycobacterium tuberculosis
Klevesath, L., Noschka, R., Vomhof, T., Mohnani, J., Grieshober, M., Michaelis, J., Walther, P., Rodríguez, A., Preising, N., Read, C., et al. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1669022 · Cited by 1
Singh, D., Parkali, P. M., Hani, U., Osmani, R., Haider, N., Kumari, J., Sriram, D., Lherbet, C., Siddappa, B. C. R., & Dixit, S. R. (2025) · RSC Advances · doi:10.1039/d5ra03004h · Cited by 1
Chien, Y.-C., Chang, C.-H., Shu, C.-C., Wang, H.-C., & Yu, C.-J. (2025) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2025.102917 · Cited by 1
Tuberculosis infection diagnosis: Current prospects.
Alcaide, F., & Anibarro, L. (2025) · Enfermedades Infecciosas y Microbiologia Clinica · doi:10.1016/j.eimc.2025.02.008 · Cited by 1
Magana-Arachchi, D., Madegedara, D., & Bandara, U. (2024) · Biochemical Genetics · doi:10.1007/s10528-024-11002-1 · Cited by 1
“…TB infection and disease, researchers have demonstrated that TB exists in a continuous spectrum: Active TB (ATB), latent TB (LTB), incipient TB (with no evidence of active Mtb), and subclinical TB (with radiological abnormalities and microbiological evidence of active Mtb) (Migliori et al. 2021).”
Murekatete, C., & Ouko, V. (2024) · International Journal of Innovative Science and Research Technology · doi:10.38124/ijisrt/ijisrt24sep467 · Cited by 1
Alshahrani, M. M., Alamri, M. A., & Alawam, A. S. (2024) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2024.126040 · Cited by 1
Ocular tuberculosis associated with Epstein-Barr virus myelitis: A case report
Alahyari, F., Halabian, R., & Nejad, J. H. (2024) · Infectious Medicine · doi:10.1016/j.imj.2024.100132 · Cited by 1
“Mycobacterium tuberculosis infection can occur directly or indirectly in organs like eyes, skin, and joints [ 13 ], with OTB manifestations resulting from active infection or immune response [ 14 ].”
BackgroundCarrero, J. C., Espinoza, B., Huerta, L., Silva‐Miranda, M., Guzmán‐Gutiérrez, S. L., Dorazco‐González, A., Reyes‐Chilpa, R., Espitia, C., & Sánchez, S. (2024) · Pharmaceuticals · doi:10.3390/ph17070957 · Cited by 3
“In most cases M. tuberculosis can be eliminated or controlled, resulting in latent infection with no visible symptoms However, an infection can occur that progresses to the active form of tuberculosis in immunosuppressed individuals [56].”
BackgroundPetruccioli, E., Petrone, L., Najafi-Fard, S., Navarra, A., Vanini, V., Cuzzi, G., Cantini, F., Gualano, G., Palmieri, F., & Goletti, D. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1271632 · Cited by 1
Self-citationFischer, H., Qian, L., Li, Z., Garba, S., Bruxvoort, K., Skarbinski, J., Ku, J., Lewin, B., Mahale, P., Shaw, S., et al. (2023) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofad545 · Cited by 1
“TB disease can later progress from LTBI through a complex spectrum of conditions, and those with LTBI have an estimated lifetime risk of 5%–10% of developing TB disease from LTBI progression [3–5].”
BackgroundDetection of Mycobacterial DNA in Human Bone Marrow
González-Escalada, A., Rebollo, M., Barrios-Payán, J., Hernández-Pando, R., & García, M. J. (2023) · Microorganisms · doi:10.3390/microorganisms11071788 · Cited by 1
“According to clinical and epidemiological data, it is considered that this infection without symptoms is not a single stage but a continuum of stages ranging from latent to incipient, then to subclinical, and ending in tuberculosis (TB) disease [2].”
BackgroundAlanzi, A. R. (2023) · International Journal of Mycobacteriology · doi:10.4103/ijmy.ijmy_149_23 · Cited by 1
Buonsenso, D. (2023) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000003946 · Cited by 1
Hino, Y., Eshima, N., Tokumaru, O., Bacal, K., Tanaka, Y., Karukaya, S., & Yamashita, Y. (2022) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2022.03.018 · Cited by 1
Murg, S. I., Moț, M., Moț, F. I., Joldea, A., Radoi, L.-I., Șandor, F. M., Bouroș-Tataru, A.-L., Firu, C., Butari, D. B., & Barata, P.-I. (2026) · Diagnostics · doi:10.3390/diagnostics16193249
“These factors continue to contribute to significant morbidity despite well-established tuberculosis control programs throughout Europe [3–5].”
Post‐Tuberculosis Lung Disease: Clinicopathologic Insights, Diagnosis, Prevention, and Management
Gopalaswamy, R., & Subbian, S. (2026) · MedComm · doi:10.1002/mco2.70974
Tuberculosis Misdiagnosed as Bronchogenic Carcinoma: A Case Report
Hosseinzadeh, P., Samadi, S., Jamshidi, S., Fayez, S. M., & Mozdourian, M. (2026) · Clinical Case Reports · doi:10.1002/ccr3.73278
Chane, E., Gebrie, E., Teketelew, B., Berta, D., Walle, M., Angelo, A., Cherie, N., Tamir, M., Abriham, Z. Y., & Mekuanint, A. (2026) · BMC Infectious Diseases · doi:10.1186/s12879-026-14086-9
“Despite significant advances in diagnosis, treatment, and prevention efforts, tuberculosis remains a significant burden, with an estimated 10.6 million new cases and 1.6 million deaths in 2022, making it one of the leading causes of death in low-and middle-income countries [2, 3].”
InfluentialEltarhony, M. S., Abd-Elsalam, N., & Belieh, A. (2026) · Egyptian Journal of Bronchology · doi:10.1186/s43168-026-00597-1
Bernardi, W. O. B., Vigato, B. F., Pelodan, M. E. P., Vinci, A., Zini, N., & Arcêncio, R. (2026) · Journal of Immigrant and Minority Health · doi:10.1007/s10903-026-01954-4
Beyond Cure: A Scoping Review of Post-Tuberculosis Long-Term Health Outcomes
Menon, S., Harries, A., Dlodlo, R., Badoum, G., Dogo, M. F., Mbitikon, O. B., Sinha, P., Lin, Y., Jaju, J., Soe, A. N., et al. (2026) · Tropical Medicine and Infectious Disease · doi:10.3390/tropicalmed11070203
Mkono, L., Sineke, N., Dlatu, N., Hosu, M. C., Apalata, T., & Faye, L. (2026) · Frontiers in Public Health · doi:10.3389/fpubh.2026.1792518
“South Africa is among the 30 highest TB-burden countries globally, with incidence rates exceeding 500 cases per 100,000 population (3, 4).”
Ramirez, L. M. N., Dobos, K., Moradian, A., Bierman, A., Shruti, R., Osei, E., Harton, M. R., Kain, D., Lewinsohn, D., Belisle, J., et al. (2026) · Scientific Data · doi:10.1038/s41597-026-07122-5
“The disease life cycle is not a linear progression from infection to asymptomatic disease to active disease, further complicating treatment decisions 2–4 .”
Och, N., Puntsag, U., Kang, S., & Choi, J.-Y. (2026) · Infection & Chemotherapy · doi:10.3947/ic.2025.0136
“Individuals with LTBI show no symptoms and are not infectious, but they carry a lifelong risk of developing active disease [4, 5].”
Complement in tuberculosis infection and disease, a battle of two ancients.
Dijkman, K., Joosten, S., & Trouw, L. (2026) · Immunobiology · doi:10.1016/j.imbio.2026.153183
Prevention, Treatment and Diagnosis of Tuberculosis, 2nd Edition
Pando, R. H. (2026) · Microorganisms · doi:10.3390/microorganisms14010163
“The disease holds a hugely significant place in human history due to the magnitude of morbidity and mortality it has brought since the beginning of civilization [1].”
Huaman, M. A., Feria, M. G., Kendall, M., McKhann, A., Supparatpinyo, K., Chougnet, C., Du, X., Sawe, F., Erlandson, K., Utay, N., et al. (2025) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaf771
“…(previously known as latent tuberculosis infection) was traditionally considered a state of mycobacterial dormancy and metabolic quiescence, studies show that there may be dynamic immune-metabolic interactions between Mtb and the human host across the spectrum of tuberculosis infection [4–6].”
Subclinical Tuberculosis Diagnosis in Lusaka, Zambia: A Case Report
Sanjase, N., Shuma, B., Ngandu, E., Muzazu, S., Mateyo, K. J., & Muyoyeta, M. (2025) · Cureus · doi:10.7759/cureus.96269
“Some studies have postulated that this may be due to the imbalance between the host immune response and bacterial activity, and as the immune system weakens or the bacterial load increases, the disease progresses to an active, symptomatic state [3,11-13].”
Khan, I., Arshad, S., Aman, W., Barkat, K., Kousar, S., Bibi, M., Mansoor, A., Arshad, R., Rahdar, A., & Ghotekar, S. (2025) · BioNanoScience · doi:10.1007/s12668-025-02197-7
“Respiratory diseases can be broadly classified into communicable, such as viral infectious diseases (e.g., tuberculosis and pneumonia), and non-communicable (NCDs), which lack an infectious cause (e.g., asthma, COPD, cystic fibrosis (CF), interstitial pulmonary fibrosis, and lung cancer) [10–12].”
Kemthong, T., Kaewparuehaschai, M., Noradechanon, K., Kongrod, K., Meesawat, S., Warit, S., Srilohasin, P., Chaiprasert, A., & Malaivijitnond, S. (2025) · Journal of the American Association for Laboratory Animal Science · doi:10.30802/aalas-jaalas-25-056
Sarkar, M. S., & Sarkar, J. (2025) · Monaldi Archives for Chest Disease · doi:10.4081/monaldi.2025.3258 · Cited by 1
Amin, W., Nafea, N., Sattar, S. A., Adawy, M. E., Ragab, N., Tohamy, A., Refaat, L., Fouad, G. A., Samad, G. A., El-Maradny, Y. A., et al. (2025) · Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace · doi:10.4081/monaldi.2025.3442
Folkesson, E., Foroogh, F., Kjellgren, V., Jakobsson, M., Grunewald, L., Hellberg, J., Silva, C., Gower, M. S., Kleberg, L., GroÌnlund, H., et al. (2025) · medRxiv · doi:10.1101/2025.05.05.25326945
Clinical features of Tibetan adolescent tuberculosis at high altitudes: a retrospective study
Shen, M., Luo, W., Luobu, B., Chen, Y.-R., Zhang, P., Qiu, R.-S., Chen, X.-R., Guo, W., & Chen, P. (2024) · BMC Pulmonary Medicine · doi:10.1186/s12890-024-03427-6
Alabi, E. D., Mzungu, I., & Tyough, V. V. (2024) · Asian Science Bulletin · doi:10.3923/asb.2024.290.296
“However, asymptomatic TB may progress into active TB infection if the immune system becomes compromised 14 .”
Genovese, C., Colaneri, M., Pagano, S., Schiuma, M., Galli, L., Fama, F., Antinori, S., Gori, A., & Torre, A. (2024) · Frontiers in Tropical Diseases · doi:10.3389/fitd.2024.1412871
Public health implications of the evolving understanding of tuberculosis natural history
Herrera, M., Taguiam, E., Laupland, K. B., Rueda, Z. V., & Keynan, Y. (2024) · Journal of the Association of Medical Microbiology and Infectious Disease Canada · doi:10.3138/jammi-2023-02-24 · Cited by 1
Arghir, I., Popoiag, C., Arghir, A. A., Ion, I., Tofolean, D., Cambrea, S., Fildan, A., Trenchea, M., & Oțelea, M. (2023) · Romanian Journal of Occupational Medicine · doi:10.2478/rjom-2023-0003
Tuberculosis: Important lessons from AOCR 2023, Bangkok, Thailand
Pakkal, M., Johari, B., Jin, M. G., Ki, Y. L., Sodhi, K. S., & Tanomkiat, W. (2023) · The ASEAN Journal of Radiology · doi:10.46475/asean-jr.v24i2.871
Nguyễn, L. T., Nguyễn, H. T. P., Nguyễn, N. T. H., & Pham, G. (2023) · Tạp chí Y học Việt Nam · doi:10.51298/vmj.v527i2.5857
“Ở các nước đang phát triển, tỷ lệ này cao hơn với 50,8% dân số mắc viêm dạ dày [1], [2].”
Agbota, G., Bonnet, M., & Lienhardt, C. (2023) · Pathogens · doi:10.3390/pathogens12030362
“Incipient patients would be an attractive group to target TB preventive treatment (TPT) [13,14].”
Biological Therapies and Tuberculosis Infection in Dermatology
Zellweger, J., & Goletti, D. (2021) · Journal of Dermatology Research Reviews & Reports · doi:10.47363/jdmrs/2021(2)134
“Within the TBI definition today there are also individuals who eliminated the mycobacteria and that show only a positive response to the immune-based tests [5-7].”
BackgroundSelf-citationDeterminants of tuberculosis treatment success in Semarang City, Indonesia
Fauzi, L., Hardanis, F. N., Anggorowati, L., & Kanthawee, P. (2026) · BIO Web of Conferences · doi:10.1051/bioconf/202624702007
Tuberculosis Presenting as Incidental Pulmonary Nodules: A Clinical Case Series and Review
Han, W., Saggar, S., & Han, P. S. (2025) · Journal of Tuberculosis Research · doi:10.4236/jtr.2025.133011
Metadata
- Authors
- Migliori, G. B., Ong, C. W. M., Petrone, L., D'Ambrosio, L., Centis, R., & Goletti, D.
- Affiliations
- Istituti Clinici Scientifici Maugeri (IT)
- National University of Singapore (SG)
- Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani (IT)
- Corresponding author
- Migliori, Giovanni Battista
- Venue
- Breathe
- Publisher
- European Respiratory Society (ERS)
- Published
- 2021-09
- Volume
- 17
- Issue
- 3
- Pages
- 210079
- ISSN
- 1810-6838 (ISSN-L)
- 2073-4735
- PMC
- PMC8753649
- OpenAlex
- W3196428738
- Cited by
- 166
- References
- 63
- Citations by year
- 2026: 24 · 2025: 43 · 2024: 33 · 2023: 38 · 2022: 25 · 2021: 3
- FWCI
- 2.90
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Licence
- Locations
- Breathe (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- National University of Singapore (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Ministero della Salute (Linea 4)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Health Sciences › Medicine › Infectious Diseases › Infectious Diseases and Tuberculosis
- Health Sciences › Medicine › Infectious Diseases › Diagnosis and treatment of tuberculosis
- Keywords
- tuberculosis infection, latent tuberculosis infection, subclinical tuberculosis, Mycobacterium tuberculosis, tuberculin skin test, interferon-gamma release assay, tuberculosis transmission, tuberculosis prevention, tuberculosis diagnosis, tuberculosis treatment, public health policy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
